Larvol Delta - Homologous-and-Heterologous-Boosting-of-the-Chadox1S1S-COVID19-Vaccine-With-the-SCB2019-Vaccine-Candidate-A-Randomized-Controlled-Phase-2-Study

SCB-2019 - Sichuan Clover Biopharma

adjuvant CpG 1018 - Dynavax

http://www.ncbi.nlm.nih.gov/pubmed/36043184

Sep 1, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next